| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10005389 | HBV | ENSG00000068024.18 | protein_coding | HDAC4 | Yes | Yes | 9759 | P56524 |
| TVIS10021176 | HBV | ENSG00000068024.18 | protein_coding | HDAC4 | Yes | Yes | 9759 | P56524 |
| TVIS10046608 | HBV | ENSG00000068024.18 | protein_coding | HDAC4 | Yes | Yes | 9759 | P56524 |
| TVIS10059727 | HBV | ENSG00000068024.18 | protein_coding | HDAC4 | Yes | Yes | 9759 | P56524 |
| TVIS10059728 | HBV | ENSG00000068024.18 | protein_coding | HDAC4 | Yes | Yes | 9759 | P56524 |
| TVIS30003243 | HIV | ENSG00000068024.18 | protein_coding | HDAC4 | Yes | Yes | 9759 | P56524 |
| TVIS30077592 | HIV | ENSG00000068024.18 | protein_coding | HDAC4 | Yes | Yes | 9759 | P56524 |
| TVIS30077564 | HIV | ENSG00000068024.18 | protein_coding | HDAC4 | Yes | Yes | 9759 | P56524 |
| TVIS30079708 | HIV | ENSG00000068024.18 | protein_coding | HDAC4 | Yes | Yes | 9759 | P56524 |
| TVIS30081909 | HIV | ENSG00000068024.18 | protein_coding | HDAC4 | Yes | Yes | 9759 | P56524 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | HDAC4 |
|---|---|
| DrugBank ID | DB01593 |
| Drug Name | Zinc |
| Target ID | BE0003523 |
| UniProt ID | P56524 |
| Regulation Type | cofactor |
| PubMed IDs | 16439135 |
| Citations | Bhuiyan MP, Kato T, Okauchi T, Nishino N, Maeda S, Nishino TG, Yoshida M: Chlamydocin analogs bearing carbonyl group as possible ligand toward zinc atom in histone deacetylases. Bioorg Med Chem. 2006 May 15;14(10):3438-46. Epub 2006 Jan 24. |
| Groups | Approved; Investigational |
| Direct Classification | Homogeneous transition metal compounds |
| SMILES | [Zn] |
| Pathways | Dihydropyrimidinase Deficiency; Rofecoxib Action Pathway; Losartan Action Pathway; AICA-Ribosiduria; Canavan Disease; Quinapril Action Pathway; Alkaptonuria; Eprosartan Action Pathway; gamma-Glutamyltransferase Deficiency; Pterine Biosynthesis; Sulindac Action Pathway; Rescinnamine Action Pathway; Piroxicam Action Pathway; Nabumetone Action Pathway; 2-Hydroxyglutric Aciduria (D and L Form); beta-Ureidopropionase Deficiency; Vitamin B6 Metabolism; Retinol Metabolism; Valsartan Action Pathway; Valdecoxib Action Pathway; Irbesartan Action Pathway; Adenosine Deaminase Deficiency; Hawkinsinuria; Methionine Metabolism; Ramipril Action Pathway; Benazepril Action Pathway; beta-Alanine Metabolism; Aspartate Metabolism; Diclofenac Action Pathway; Galactosemia |
| PharmGKB | PA451956 |
| ChEMBL | CHEMBL1201279 |
